Status:
COMPLETED
Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study
Lead Sponsor:
AstraZeneca
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
18-79 years
Brief Summary
The purpose of the study is to determine the applicability and utility of Gerd Q in the diagnosis of GERD and in the assessment of treatment response.
Eligibility Criteria
Inclusion
- Patients of either gender aged between 18-79 years of age
- Patients must be having symptoms of gastroesophageal reflux disease
Exclusion
- None
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00963144
Start Date
July 1 2009
End Date
November 1 2009
Last Update
October 21 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Kuala Lumpur, Malaysia
2
Research Site
Kuala Selangor, Malaysia